Target Price | $109.42 |
Price | $94.78 |
Potential | 15.44% |
Number of Estimates | 36 |
36 Analysts have issued a price target Walmart 2026 . The average Walmart target price is $109.42. This is 15.44% higher than the current stock price. The highest price target is $120.00 26.61% , the lowest is $91.00 3.99% . | |
A rating was issued by 43 analysts: 38 Analysts recommend Walmart to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Walmart stock has an average upside potential 2026 of 15.44% . Most analysts recommend the Walmart stock at Purchase. |
35 Analysts have issued a sales forecast Walmart 2026 . The average Walmart sales estimate is $706b . This is 3.73% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $725b 6.44% , the lowest is $697b 2.37% .
This results in the following potential growth metrics:
2025 | $681b | 5.07% |
---|---|---|
2026 | $706b | 3.73% |
2027 | $738b | 4.48% |
2028 | $773b | 4.73% |
2029 | $804b | 4.05% |
2030 | $839b | 4.35% |
25 Analysts have issued an Walmart EBITDA forecast 2026. The average Walmart EBITDA estimate is $45.3b . This is 7.10% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $49.2b 16.25% , the lowest is $44.1b 4.26% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $42.3b | 8.89% |
---|---|---|
2026 | $45.3b | 7.10% |
2027 | $49.0b | 8.04% |
2028 | $53.5b | 9.16% |
2029 | $55.3b | 3.45% |
2030 | $59.1b | 6.87% |
2025 | 6.21% | 3.64% |
---|---|---|
2026 | 6.42% | 3.30% |
2027 | 6.63% | 3.27% |
2028 | 6.92% | 4.37% |
2029 | 6.88% | 0.58% |
2030 | 7.04% | 2.33% |
16 Analysts have issued a Walmart forecast for earnings per share. The average Walmart <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.64 . This is 9.54% higher than earnings per share in the financial year 2025. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.76 14.52% , the lowest is $2.56 6.22% .
This results in the following potential growth metrics and future valuations:
2025 | $2.41 | 26.18% |
---|---|---|
2026 | $2.64 | 9.54% |
2027 | $2.96 | 12.12% |
2028 | $3.35 | 13.18% |
2029 | $4.13 | 23.28% |
Current | 39.38 | 39.25% |
---|---|---|
2026 | 35.96 | 8.68% |
2027 | 32.05 | 10.87% |
2028 | 28.32 | 11.64% |
2029 | 22.95 | 18.96% |
Based on analysts' sales estimates for 2026, the Walmart stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.16 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.08 .
This results in the following potential growth metrics and future valuations:
Current | 1.20 | 46.34% |
---|---|---|
2026 | 1.16 | 3.37% |
2027 | 1.11 | 4.29% |
2028 | 1.06 | 4.51% |
2029 | 1.02 | 3.89% |
2030 | 0.98 | 4.17% |
Current | 1.12 | 55.72% |
---|---|---|
2026 | 1.08 | 3.60% |
2027 | 1.03 | 4.29% |
2028 | 0.99 | 4.52% |
2029 | 0.95 | 3.89% |
2030 | 0.91 | 4.17% |
Analyst | Rating | Action | Date |
---|---|---|---|
Telsey Advisory Group | Outperform ➜ Outperform | Unchanged | Feb 21 2025 |
Keybanc | Overweight ➜ Overweight | Unchanged | Feb 21 2025 |
RBC Capital | Outperform ➜ Outperform | Unchanged | Feb 21 2025 |
Piper Sandler | Overweight ➜ Overweight | Unchanged | Feb 21 2025 |
UBS | Buy ➜ Buy | Unchanged | Feb 21 2025 |
Roth MKM | Buy ➜ Buy | Unchanged | Feb 21 2025 |
Piper Sandler | Overweight ➜ Overweight | Unchanged | Feb 18 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Telsey Advisory Group: Outperform ➜ Outperform
|
Feb 21 2025 |
Unchanged
Keybanc: Overweight ➜ Overweight
|
Feb 21 2025 |
Unchanged
RBC Capital: Outperform ➜ Outperform
|
Feb 21 2025 |
Unchanged
Piper Sandler: Overweight ➜ Overweight
|
Feb 21 2025 |
Unchanged
UBS: Buy ➜ Buy
|
Feb 21 2025 |
Unchanged
Roth MKM: Buy ➜ Buy
|
Feb 21 2025 |
Unchanged
Piper Sandler: Overweight ➜ Overweight
|
Feb 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.